Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study.

J. Wedzicha | J. Vonk | K. Bønnelykke | C. Larminie | A. Zwinderman | L. Fabbri | A. Agustí | M. Nawijn | J. Pellet | A. Mazein | R. Lutter | S. Dahlén | K. Sun | B. De Meulder | D. Lefaudeux | K. Chung | R. Djukanović | G. Pratico | G. Donaldson | W. Boersma | H. Kerstjens | P. J. Sterk | Richard Graham Knowles | L. Lahousse | N. Jullian | M. Boedigheimer | A. Spanevello | F. Crispi | P. Brinkman | R. Stelmach | J. de Batlle | C. Wheelock | A. Chaiboonchoe | H. Ahmed | C. Rossios | A. Chetta | R. Olivenstein | I. Delin | A. James | M. Broeders | N. Scichilone | L. Vanfleteren | E. Pizzichini | M. Kraft | R. Faner | T. Sigsgaard | L. Nicod | G. Kerry | P. Latzin | D. Campagna | A. Cukier | A. H. Maitland‐van der Zee | J. Stokholm | B. Cosío | U. Hoda | J. Hohlfeld | M. van den Berge | S. Hartl | R. Schilz | G. Nicolini | T. van der Molen | J. Vestbo | G. Gálffy | L. Tamási | A. Sogbesan | A. Menzies-Gow | N. Mores | J. Hallberg | K. Fichtner | A. Papi | K. Kretsos | E. Mélen | W. van Aalderen | C. Casaulta | U. Nihlén | S. Milleri | M. Klüglich | P. Dodson | A. Behndig | J. Konradsen | A. Berglind | M. Breyer | L. Krueger | A. Bush | R. Breyer-Kohansal | P. Badorrek | K. Tariq | J. Allinson | A. Manta | N. Hanania | M. Gahlemann | Ann-Sofie Lantz | C. Vogelmeier | S. Siddiqui | O. Burghuber | J. Wedzicha | Q. Zhang | C. Faulenbach | P. Paggiaro | J. Bigler | A. Agustí | M. P. Foschino | F. Barbé | K. Vellvé | K. Rabe | G. Santini | E. Formaggio | N. Fitch | B. Nordlund | M. Sunther | V. Plaza Moral | M. D'amato | I. Adcock | J. Vroegop | J. Fitting | R. Martin | A. Vyas | J. P. Rocha | E. Henriksson | T. Kole | Elise Vanden Berghe | C. Brightling | Dave Singh | C. Gessner | D. Postma | O. Usmani | D. Allen | S. Ballereau | M. Batuwitage | A. Bedding | A. Berton | T. Davison | P. Dennison | L. El Hadjam | D. Erzen | D. Garissi | T. Garret | E. Guillmant-Farry | X. Hu | K. Johnson | N. Lemonnier | L. A. Lowe | L. McEvoy | C. S. Murray | K. Nething | R. Niven | S. Nsubuga | C. Pison | M. Puig Valls | K. Riemann | M. Sági | S. Scott | N. Sehgal | A. Selby | P. Söderman | F. Spycher | S. Stephan | M. Szentkereszty | S. Valente | C. van Drunen | J. van Eyll | W. Yu | W. Zetterguist | Z. Zolkipli | P. Alter | M. Casas | J. Garcia | D. Jarvis | A. Mathioudakis | A. Ritchie | A. Ullman | A. Wheelock | P. Sterk | D. Singh | W. Yu | A. Agusti | Ann‐Sofie Lantz | C. V. van Drunen

[1]  K. Rabe,et al.  The role of small airway dysfunction in asthma control and exacerbations: a longitudinal, observational analysis using data from the ATLANTIS study. , 2022, The Lancet. Respiratory medicine.

[2]  J. Virchow,et al.  Extrafine triple therapy in patients with asthma and persistent airflow limitation , 2020, European Respiratory Journal.

[3]  J. Vonk,et al.  Differential DNA methylation in bronchial biopsies between persistent asthma and asthma in remission , 2019, European Respiratory Journal.

[4]  D. Postma,et al.  Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study. , 2019, The Lancet. Respiratory medicine.

[5]  A. Agustí,et al.  Lung function trajectories in health and disease. , 2019, The Lancet. Respiratory medicine.

[6]  C. Brightling,et al.  Asthma , 2018, The Lancet.

[7]  J. Steinberg,et al.  Risk factors and clinical outcomes associated with fixed airflow obstruction in older adults with asthma. , 2017, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[8]  K. Kostikas,et al.  Persistent airflow obstruction in patients with asthma: Characteristics of a distinct clinical phenotype. , 2015, Respiratory medicine.

[9]  Ioannis Pandis,et al.  Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort , 2015, European Respiratory Journal.

[10]  D. Postma,et al.  Unmet needs for the assessment of small airways dysfunction in asthma: introduction to the ATLANTIS study , 2015, European Respiratory Journal.

[11]  R. Costanza,et al.  Clinical significance of small airway obstruction markers in patients with asthma , 2014, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[12]  Michael Engel,et al.  Tiotropium in asthma poorly controlled with standard combination therapy. , 2012, The New England journal of medicine.

[13]  S. Stanojevic,et al.  Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations , 2012, European Respiratory Journal.

[14]  L. Fabbri,et al.  Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up. , 2010, The Journal of allergy and clinical immunology.

[15]  C. Lemière,et al.  Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction. , 2009, The Journal of allergy and clinical immunology.

[16]  S. Wenzel,et al.  Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study. , 2007, Chest.

[17]  I. Pavord,et al.  Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma , 2007, Thorax.

[18]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[19]  A. Zwinderman,et al.  Factors associated with persistent airflow limitation in severe asthma. , 2001, American journal of respiratory and critical care medicine.